Two cheap, safe, and already approved drugs could help treat lacunar stroke a leading cause of dementia. Each one lead to improvement but combined they were even better.
A combination of two drugs showed promising phase 2 results, including a reduction in cognitive impairment in patients with lacunar stroke, and may be a potential new approach to small vessel disease.
A study of two widely used cardiovascular medications cilostazol and isosorbide mononitrate in more than 350 patients confirmed the two medications were well-tolerated and safe for people who have experienced a stroke in a small blood vessel deep in the brain.
A preliminary study of two common cardiovascular medications, cilostazol and isosorbide mononitrate, suggests these two medications were safe and well-tolerated by adults who have experienced small vessel stroke, when taken alone or together